Related Experiment Videos
Where and how must we perform noninvasive mechanical ventilation?
1S. Maugeri Foundation, IRCCS, Respiratory Division, Medical Center of Rehabilitation, Gussago, Brescia, Italy.
Summary
Noninvasive mechanical ventilation (NMV) is a vital therapy for severe chronic obstructive pulmonary disease (COPD) relapses, reducing mortality and ICU stays. This approach offers an optimal cost-benefit ratio in intermediate intensive care units for selected patients.
Area of Science:
- Pulmonary Medicine
- Critical Care Medicine
Background:
- Mechanical ventilation (MV) is evolving with noninvasive ventilatory assistance (NMV) in Intermediate Intensive Care Units (IICUs).
- Severe relapses of chronic obstructive pulmonary disease (COPD) necessitate NMV for improved patient outcomes.
Purpose of the Study:
- To evaluate the role and benefits of NMV in managing acute on chronic respiratory insufficiency, particularly in COPD patients.
- To establish the suitability of IICUs for providing intermediate care for COPD patients requiring ventilatory support.
Main Methods:
- Review of current practices integrating NMV into IICU settings.
- Analysis of NMV's impact on mortality, morbidity, and Intensive Care Unit (ICU) length of stay compared to standard therapy.
- Discussion of requirements for an ideal MV monitoring system and IICU standards.
Main Results:
- NMV significantly reduces mortality, morbidity, and ICU time for severe COPD relapses compared to standard medical therapy alone.
- Malnutrition and high APACHE II scores are poor prognostic indicators in COPD patients requiring MV.
- IICUs offer a cost-effective alternative for managing less severe acute respiratory failure (ARF) in COPD patients, optimizing resource utilization.
Conclusions:
- NMV should be considered for routine care in selected patients after system optimization and staff training.
- Dedicated pulmonary intensivists and nurses with specialized training are crucial for effective intensive respiratory care.
- IICUs provide a valuable intermediate care setting for COPD patients, improving cost-benefit ratios and reducing unnecessary ICU admissions.